Clinical Trials Logo

Clinical Trial Summary

Canadian multicentre prospective cohort study of 40 patients with ischaemic heart disease and therapy from an implantable cardioverter defibrillator (ICD).


Clinical Trial Description

Paced Electrogram Feature Analysis is employed to elucidate VT isthmus sites and target Type I sites for ablation to prevent recurrent VT/VF. The trial hypothesis is: catheter ablation employing PEFA will, in comparison to published data, reduce the composite outcome of death at any time, appropriate ICD shock, ventricular tachycardia storm or treated sustained ventricular tachycardia below the detection rate of the ICD or incessant VT for patients with prior myocardial infarction and sustained ventricular tachycardia or fibrillation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03870854
Study type Interventional
Source Queen's University
Contact Dmitry Uchitel
Phone 613-533-2148
Email dmitry.uchitel@kingstonhsc.ca
Status Recruiting
Phase N/A
Start date August 13, 2019
Completion date September 30, 2025